hg_130807.1

Basic information about the TSS

---

TSS ID: hg_130807.1 Species: human Chr: chr12		Start: 49110840 End: 49110856 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000547382.5 ENST00000457164.6 ENST00000550137.5 ENST00000549296.1 ENST00000548983.1 uc001rti.5 uc058nng.1 uc058nnm.1 uc058nnp.1 uc058nnu.1 AK001651 AK298026 Distance: 0 GeneID: 55716 HGNC/MGI_ID: HGNC:18268 UniProt_ID: B4DNR6 E7ESX7 F8VPB1 F8VYZ9 Q6UX01

Gene_name: limb development membrane protein 1 like Gene_symbol: LMBR1L Gene_synonyms: FLJ10494 KIAA1174 Gene_source: HGNC:18268

TATA-Box annotation

---

Distance to TSS:	52
Nearest PromoterID:	NM_001300750
Entrez ID:	55716
Nearest Unigene:	Hs.272838
Nearest Refseq:	NM_018113
Nearest Ensembl:	ENSG00000139636
Gene Name:	limb development membrane protein 1 like
Gene Alias:	LIMR
Gene Description:	limb development membrane protein 1 like
Gene Type:	protein-coding
CpG%:	0.065
GC%:	0.567164
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):	"49(GACCTTAAAGAG,-,0.00),51(CCTTAAAGAGTG,+,0.00),83(GCCCTTTAAAAC,-,0.00),84(CCCTTTAAAACG,+,0.00),85(CCTTTAAAACGA,+,0.00)"

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@LMBR1L p2@LMBR1L p3@LMBR1L
Sample		p1@LMBR1L	p2@LMBR1L	p3@LMBR1L
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	4.68	18.51	4.29
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	5.06	22.05	4.25
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	4.24	19.10	6.17
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	5.61	16.42	3.95
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	4.50	19.35	4.05
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	7.56	15.31	3.29
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	6.54	20.26	5.88
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	5.33	19.14	5.09
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	4.70	22.65	4.70
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	9.27	60.28	7.54
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	7.68	49.72	10.51
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	13.42	49.60	6.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	25.47	5.32	4.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	23.15	4.81	4.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	22.39	6.37	3.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	20.37	3.02	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	18.13	4.15	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	19.40	3.80	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	21.86	5.33	3.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	25.58	4.06	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	21.38	3.88	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	20.02	5.35	2.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	17.45	3.36	2.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	16.26	2.67	3.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	22.70	4.64	3.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	22.16	3.17	3.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	18.68	5.49	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	20.51	3.54	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	19.38	5.65	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	15.02	3.80	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	15.91	3.35	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	16.61	3.52	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	14.77	2.74	3.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	11.05	4.29	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	13.28	2.80	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	16.67	2.87	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	12.26	4.50	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11.08	2.62	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	11.07	3.51	2.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	11.52	3.36	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.47	4.47	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	11.42	3.22	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	17.93	3.16	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	18.36	5.07	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	18.87	6.83	2.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	18.61	6.51	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	17.03	7.44	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	16.69	7.75	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	20.83	4.55	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	20.62	6.07	2.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	21.93	5.53	2.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	19.12	6.23	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	22.71	3.55	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	17.89	5.63	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	6.71	9.23	5.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	11.02	8.27	5.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	22.36	5.51	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	17.99	4.18	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	14.46	9.12	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	20.45	2.82	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	26.36	5.05	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.17	9.55	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	16.99	9.51	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	27.94	7.80	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	21.65	4.61	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.29	4.88	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	6.94	6.45	4.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.85	5.63	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	5.63	3.31	6.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.83	3.09	3.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.95	3.67	6.42
Adipocyte - breast, donor1	11376-118A8	9.34	4.91	1.58
Adipocyte - breast, donor2	11327-117E4	7.70	1.28	1.12
Adipocyte - omental, donor1	11473-119C6	6.36	2.42	0.76
Adipocyte - omental, donor2	11474-119C7	8.22	3.74	0.00
Adipocyte - omental, donor3	11475-119C8	5.69	3.35	0.00
Adipocyte - perirenal, donor1	11476-119C9	6.38	3.19	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	6.60	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	3.16	1.35	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	6.43	1.91	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	16.23	3.32	1.76
Adipocyte differentiation, day04, donor2	13022-139D7	21.88	4.63	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	14.22	4.18	1.67
Adipocyte differentiation, day04, donor4	13028-139E4	20.57	1.76	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	7.56	1.45	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	8.71	1.94	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	10.13	1.60	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	10.02	1.67	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	9.98	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	11.80	2.01	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	12.76	1.96	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	9.44	0.91	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	6.63	9.72	2.43
Alveolar Epithelial Cells, donor2	11590-120G6	8.25	11.12	2.15
Alveolar Epithelial Cells, donor3	11671-122G6	11.98	9.58	4.79
Amniotic Epithelial Cells, donor1	11533-120A3	10.61	9.00	3.24
Amniotic Epithelial Cells, donor2	11613-122A2	25.10	3.35	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	18.08	9.45	4.31
Anulus Pulposus Cell, donor1	11248-116E6	14.76	1.03	1.95
Anulus Pulposus Cell, donor2	11463-119B5	12.74	1.47	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	15.28	6.29	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	17.80	6.08	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	19.43	5.08	1.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	11.38	6.32	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	19.14	4.62	3.96
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	19.49	4.87	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	15.53	5.34	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	19.00	4.16	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.05	3.77	2.26
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.79	5.81	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	11.28	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	12.03	5.11	1.48
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	15.01	4.09	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	16.13	3.62	0.90
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	16.61	4.29	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	16.82	3.59	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	17.37	1.87	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	12.68	2.93	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	16.59	2.16	1.82
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	10.81	2.40	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	25.04	4.29	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	16.50	1.46	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	18.59	5.69	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	21.80	8.48	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	17.67	5.13	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	20.31	4.28	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	29.42	2.32	2.06
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	15.01	7.04	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	20.26	3.86	2.57
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	17.12	2.85	2.14
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	18.13	1.75	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	23.18	4.22	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	22.57	4.75	4.75
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	20.85	4.58	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	17.83	3.82	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	17.15	2.54	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	18.12	2.59	1.73
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	16.93	3.39	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	21.17	3.48	2.32
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	20.78	6.61	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	16.61	3.73	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	25.35	6.34	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	14.37	4.93	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	21.06	1.80	3.01
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	11.66	4.37	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	16.32	4.14	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	16.02	2.03	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	17.75	4.54	1.86
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	22.03	3.67	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	22.47	5.74	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	18.85	3.55	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	15.51	1.66	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	20.12	4.77	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	19.99	3.63	1.09
Astrocyte - cerebellum, donor1	11500-119F6	7.98	8.72	1.47
Astrocyte - cerebellum, donor2	11580-120F5	10.10	4.79	1.54
Astrocyte - cerebellum, donor3	11661-122F5	13.00	7.13	4.82
Astrocyte - cerebral cortex, donor1	11235-116D2	7.67	9.76	5.23
Astrocyte - cerebral cortex, donor2	11316-117D2	6.79	5.82	3.07
Astrocyte - cerebral cortex, donor3	11392-118C6	5.97	4.77	5.07
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	4.36	4.70	8.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	2.00	3.76	7.02
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	3.87	4.55	7.51
Basophils, donor1	12241-129G9	27.72	6.02	3.14
Basophils, donor2	12242-129H1	35.00	3.25	3.61
Basophils, donor3	12243-129H2	19.99	2.06	1.32
Bronchial Epithelial Cell, donor1	11511-119G8	3.02	3.23	1.72
Bronchial Epithelial Cell, donor2	11591-120G7	6.40	4.57	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	8.16	6.28	1.88
Bronchial Epithelial Cell, donor5	11457-119A8	7.49	4.37	1.46
Bronchial Epithelial Cell, donor6	11461-119B3	6.68	3.22	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	5.76	1.80	2.70
Burkitt's lymphoma cell line:DAUDI	10422-106C8	5.77	3.30	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	6.99	3.49	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	7.35	4.16	3.84
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	20.68	10.34
CD14+ Monocytes, donor1	11224-116B9	33.81	2.25	3.38
CD14+ Monocytes, donor2	11305-117B9	36.19	2.23	2.04
CD14+ Monocytes, donor3	11381-118B4	46.32	2.41	3.07
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	23.78	4.81	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	28.05	2.65	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	24.33	3.94	2.30
CD14+ monocytes - mock treated, donor1	11863-125A9	26.89	3.76	1.30
CD14+ monocytes - mock treated, donor2	11873-125C1	14.48	2.11	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	20.37	3.55	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	12.39	2.18	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	10.21	4.97	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	14.63	5.45	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	14.10	3.13	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	14.78	4.10	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	12.62	5.66	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	14.05	4.68	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	18.48	8.45	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	28.84	9.98	3.33
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	16.81	3.72	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	9.78	2.00	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	11.45	4.58	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	13.27	2.75	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	8.14	3.39	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	15.28	6.55	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	23.67	5.38	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	24.95	5.41	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	28.62	7.15	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	9.37	2.20	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.58	3.52	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	11.41	3.51	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	19.18	6.10	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	19.70	6.69	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	20.91	10.35	1.29
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	11.06	4.09	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	8.81	3.25	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.96	4.64	0.93
CD14+CD16+ Monocytes, donor1	11789-124B7	13.95	5.23	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	14.32	3.93	2.77
CD14+CD16+ Monocytes, donor3	11912-125G4	14.51	6.28	2.38
CD14+CD16- Monocytes, donor1	11788-124B6	27.87	4.67	3.43
CD14+CD16- Monocytes, donor2	11799-124C8	23.05	3.49	2.79
CD14+CD16- Monocytes, donor3	11910-125G2	20.51	3.12	2.68
CD14-CD16+ Monocytes, donor1	11790-124B8	13.78	6.63	3.32
CD14-CD16+ Monocytes, donor2	11800-124C9	12.30	4.17	5.05
CD14-CD16+ Monocytes, donor3	11911-125G3	12.21	4.63	3.37
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	38.61	6.10	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	33.22	6.10	4.75
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	42.46	12.43	4.14
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	39.44	5.86	3.73
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	44.49	6.43	6.97
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	42.82	9.13	6.32
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	47.85	10.20	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	34.28	5.27	7.91
CD19+ B Cells, donor1	11544-120B5	74.79	1.64	8.22
CD19+ B Cells, donor2	11624-122B4	76.17	3.63	4.35
CD19+ B Cells, donor3	11705-123B4	77.24	5.05	2.52
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	2.42	0.81	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	2.80	2.00	2.40
CD34+ Progenitors, donor1	11545-120B6	16.06	8.03	6.02
CD34+ Progenitors, donor2	11625-122B5	29.78	6.18	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	9.77	5.64	3.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	5.64	5.41	5.86
CD4+ T Cells, donor1	11225-116C1	68.91	6.43	18.57
CD4+ T Cells, donor2	11306-117C1	87.57	4.29	20.82
CD4+ T Cells, donor3	11382-118B5	82.96	11.28	11.28
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	20.93	10.46	8.93
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	37.73	14.82	14.60
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	39.38	14.95	15.52
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	73.48	16.59	26.08
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	70.93	23.18	23.88
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	98.89	16.48	13.18
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	25.00	6.79	8.53
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	32.37	5.59	8.47
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	36.59	10.32	8.87
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	49.76	15.24	12.55
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	41.23	11.18	13.63
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	50.16	11.88	11.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	17.71	10.54	9.28
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	19.11	8.73	9.97
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	23.72	9.69	5.68
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	49.76	11.15	24.47
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	66.46	20.90	34.30
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	60.97	12.55	28.69
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	25.77	6.12	7.05
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	23.39	7.80	7.80
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	34.89	5.67	7.36
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	46.52	9.10	21.24
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	48.52	8.67	20.36
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	45.76	15.69	18.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	50.48	17.82	19.30
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	36.00	8.31	5.54
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	33.50	6.98	8.37
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	37.39	11.35	5.26
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	36.56	12.51	6.63
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	35.42	12.32	15.40
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	46.56	14.68	17.91
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	37.39	11.08	13.85
CD8+ T Cells, donor1	11226-116C2	72.03	3.60	10.48
CD8+ T Cells, donor2	11307-117C2	96.49	4.51	8.63
CD8+ T Cells, donor3	11383-118B6	103.02	4.04	11.36
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	2.52	9.41	1.61
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	3.12	8.39	3.59
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	4.10	6.02	3.56
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.50	9.61	4.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	2.64	7.20	4.56
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	3.87	5.68	3.41
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	3.48	10.43	4.56
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	4.21	10.00	1.58
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	4.46	8.68	3.28
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	6.04	6.94	3.32
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	2.61	8.13	3.78
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	2.40	6.13	3.20
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	17.95	11.82	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	17.76	13.66	3.19
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	16.41	11.93	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	6.12	9.00	2.88
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	6.62	8.63	3.16
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.24	5.19	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	3.17	10.46	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.92	12.61	4.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	3.53	8.98	2.56
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	2.68	8.80	2.29
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	4.73	8.28	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4.54	6.05	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	27.30	29.71	7.23
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	17.49	23.78	6.99
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	18.03	23.04	9.02
Cardiac Myocyte, donor1	11525-119I4	23.76	10.97	0.00
Cardiac Myocyte, donor2	11605-120I3	25.69	6.42	1.48
Cardiac Myocyte, donor3	11686-122I3	4.31	7.47	2.53
Chondrocyte - de diff, donor1	11261-116G1	11.09	0.69	0.35
Chondrocyte - de diff, donor2	11338-117F6	10.66	4.26	0.71
Chondrocyte - de diff, donor3	11410-118E6	15.13	1.93	1.48
Chondrocyte - re diff, donor2	11339-117F7	9.85	2.69	0.90
Chondrocyte - re diff, donor3	11411-118E7	19.01	6.07	4.04
Ciliary Epithelial Cells, donor1	11242-116D9	3.79	5.62	4.93
Ciliary Epithelial Cells, donor2	11323-117D9	4.49	6.20	4.70
Ciliary Epithelial Cells, donor3	11399-118D4	6.37	7.52	4.16
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	22.83	17.42	10.18
Corneal Epithelial Cells, donor1	11526-119I5	7.69	2.20	1.98
Corneal Epithelial Cells, donor2	11606-120I4	3.41	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	10.23	3.07	2.30
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	35.99	19.48	0.99
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	35.33	16.72	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	24.15	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	29.05	17.93	1.84
Dendritic Cells - plasmacytoid, donor1	11228-116C4	16.40	3.76	8.20
Dendritic Cells - plasmacytoid, donor2	11309-117C4	25.46	2.61	4.57
Dendritic Cells - plasmacytoid, donor3	11385-118B8	18.39	2.90	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	9.51	9.84	2.33
Endothelial Cells - Aortic, donor1	11263-116G3	19.36	17.02	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	13.29	13.57	2.26
Endothelial Cells - Aortic, donor3	11412-118E8	16.91	9.04	2.75
Endothelial Cells - Artery, donor1	11264-116G4	25.60	14.54	2.62
Endothelial Cells - Artery, donor2	11341-117F9	17.18	14.12	4.24
Endothelial Cells - Artery, donor3	11413-118E9	9.64	10.52	2.45
Endothelial Cells - Lymphatic, donor1	11236-116D3	16.62	17.29	3.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	14.91	18.86	2.74
Endothelial Cells - Lymphatic, donor3	11393-118C7	10.15	17.20	1.69
Endothelial Cells - Microvascular, donor1	11265-116G5	13.37	21.69	1.78
Endothelial Cells - Microvascular, donor2	11342-117G1	17.70	19.26	5.73
Endothelial Cells - Microvascular, donor3	11414-118F1	14.46	22.12	5.53
Endothelial Cells - Thoracic, donor1	11266-116G6	17.61	14.80	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	16.25	32.50	4.19
Endothelial Cells - Umbilical vein, donor1	11243-116E1	9.07	12.55	6.71
Endothelial Cells - Umbilical vein, donor2	11324-117E1	10.21	9.99	1.52
Endothelial Cells - Umbilical vein, donor3	11400-118D5	6.35	10.14	2.93
Endothelial Cells - Vein, donor1	11267-116G7	18.20	15.93	1.14
Endothelial Cells - Vein, donor2	11344-117G3	7.68	19.56	4.89
Endothelial Cells - Vein, donor3	11416-118F3	14.60	17.74	6.59
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	82.51	36.31	29.70
Eosinophils, donor3	12246-129H5	39.24	24.97	10.70
Esophageal Epithelial Cells, donor1	11507-119G4	4.40	3.42	1.47
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	6.24	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	18.47	3.28	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	16.86	4.38	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	18.74	3.14	2.06
Fibroblast - Aortic Adventitial, donor1	11245-116E3	9.70	4.37	2.06
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	34.66	18.29	3.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	14.34	3.90	0.95
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	26.88	17.13	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	18.27	4.32	1.66
Fibroblast - Cardiac, donor1	11268-116G8	11.79	4.99	2.27
Fibroblast - Cardiac, donor2	11345-117G4	14.40	18.95	6.06
Fibroblast - Cardiac, donor3	11417-118F4	16.09	8.20	3.79
Fibroblast - Cardiac, donor4	11452-119A3	7.88	2.73	1.82
Fibroblast - Cardiac, donor5	11456-119A7	10.28	8.12	1.27
Fibroblast - Cardiac, donor6	11460-119B2	8.49	7.73	1.06
Fibroblast - Choroid Plexus, donor1	11492-119E7	5.36	7.50	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.20	3.88	2.16
Fibroblast - Choroid Plexus, donor3	11653-122E6	2.93	5.86	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	16.84	2.77	3.00
Fibroblast - Conjunctival, donor3	11692-122I9	15.09	4.24	3.56
Fibroblast - Dermal, donor1	11269-116G9	11.27	1.41	1.64
Fibroblast - Dermal, donor2	11346-117G5	4.25	7.55	1.89
Fibroblast - Dermal, donor3	11418-118F5	9.07	1.33	2.18
Fibroblast - Dermal, donor4	11450-119A1	3.96	1.92	0.57
Fibroblast - Dermal, donor5	11454-119A5	3.84	3.31	0.87
Fibroblast - Dermal, donor6	11458-119A9	3.90	2.60	0.65
Fibroblast - Gingival, donor1	11237-116D4	9.79	0.62	2.08
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	20.70	2.36	1.57
Fibroblast - Gingival, donor2	11318-117D4	9.75	2.50	1.84
Fibroblast - Gingival, donor3	11394-118C8	10.54	0.68	1.26
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	10.39	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	13.57	1.23	1.76
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	14.97	3.74	2.18
Fibroblast - Gingival, donor6 (control)	11922-125H5	11.49	1.49	1.49
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	10.59	1.41	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	16.38	2.05	1.32
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	13.09	1.64	1.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	7.13	1.65	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	23.62	3.23	1.91
Fibroblast - Lung, donor1	11270-116H1	31.27	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	13.43	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	17.09	0.42	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	6.66	0.83	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	6.99	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	17.07	3.36	1.40
Fibroblast - Mammary, donor1	11540-120B1	18.27	5.68	3.65
Fibroblast - Mammary, donor2	11620-122A9	11.98	7.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	6.01	1.36	2.72
Fibroblast - Periodontal Ligament, donor2	11319-117D5	6.07	3.64	4.40
Fibroblast - Periodontal Ligament, donor3	11395-118C9	6.12	0.61	2.45
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	12.59	1.14	2.29
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	14.85	2.43	1.62
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	12.29	0.58	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	4.97	7.18	2.10
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	13.61	7.11	4.06
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	10.69	0.67	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	8.70	2.77	2.77
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	16.87	8.93	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	12.79	2.84	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	11.83	2.96	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	20.76	8.72	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	9.72	2.48	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	29.86	8.10	0.76
Fibroblast - skin normal, donor1	11553-120C5	13.29	1.97	1.64
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	14.64	4.41	1.40
Fibroblast - skin normal, donor2	11561-120D4	9.95	3.11	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	30.83	6.95	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	12.92	2.57	1.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	13.16	2.05	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	29.23	11.50	2.30
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	9.48	3.41	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	8.43	2.87	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	10.19	2.82	2.51
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	28.76	5.23	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	15.26	5.03	1.21
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	13.79	7.55	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	11.50	4.34	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	13.78	8.42	4.59
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	14.04	8.93	5.74
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	3.71	19.68	9.98
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	12.68	9.38	20.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	9.82	13.93	16.90
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	5.94	12.28	10.90
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	13.48	6.61	18.50
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	16.96	15.00	8.15
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	4.42	13.71	7.96
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	4.24	11.31	14.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	4.93	10.59	10.34
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	5.37	9.13	9.67
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	4.21	16.85	11.03
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	4.29	15.37	13.29
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	5.69	13.62	9.35
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	6.85	20.54	10.04
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	4.24	17.07	11.58
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	7.43	19.02	13.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	5.91	15.07	14.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	7.31	16.85	8.42
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	5.59	13.63	10.05
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	5.24	14.92	10.69
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	6.45	16.12	5.94
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	4.97	15.61	9.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	4.47	13.94	16.23
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	7.17	18.61	14.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	6.20	14.50	6.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	6.74	14.98	9.07
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	9.80	17.15	8.17
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	8.25	18.15	10.11
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	8.76	18.10	11.76
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	9.67	19.68	15.01
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	9.04	14.99	13.01
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	8.98	17.59	10.58
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	10.70	19.61	11.02
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	9.30	17.96	14.75
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	6.25	15.07	9.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	7.12	16.61	10.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	9.43	11.86	11.56
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	5.65	17.88	8.89
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	10.98	15.59	12.51
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	10.10	17.11	9.82
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	10.65	14.26	5.18
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	9.36	15.24	4.01
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	10.86	13.46	4.44
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	9.59	16.06	4.40
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	8.95	15.18	5.42
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	16.04	15.12	3.50
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	10.09	19.30	8.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	12.89	14.88	10.91
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	14.38	10.55	4.49
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	14.53	10.69	3.43
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	11.95	14.49	3.30
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	3.38	9.36	4.78
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	2.31	8.63	14.33
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	4.30	8.80	9.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	8.14	10.33	7.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	4.24	5.65	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	9.69	6.92	9.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	17.32	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	7.35	18.18	3.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	11.23	22.46	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	19.13	31.30	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	9.11	11.72	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	11.53	11.53	3.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	13.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	6.43	11.19	4.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	5.23	9.48	3.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	9.23	10.07	7.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	10.18	12.40	4.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	5.77	11.21	4.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	0.00	16.71	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	6.87	9.16	8.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	8.29	8.88	5.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	8.47	16.94	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	15.33	16.98	2.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	13.35	10.36	2.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	14.99	10.38	2.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	14.02	11.41	3.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	14.71	12.04	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	11.56	10.40	6.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	10.27	8.56	2.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	7.45	32.30	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	9.91	11.32	10.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	6.64	15.69	6.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	8.65	12.72	10.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	6.78	9.57	7.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	10.85	14.80	9.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	9.44	20.07	12.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	12.84	15.17	5.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	12.73	22.38	10.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	12.72	12.72	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	10.15	15.52	5.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	12.62	13.59	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	14.84	3.42	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	11.23	0.42	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	2.25	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	16.49	2.22	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	14.20	2.09	1.67
Hep-2 cells mock treated, biol_rep1	11898-125E8	2.44	1.28	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	1.86	3.04	1.35
Hep-2 cells mock treated, biol_rep3	11900-125F1	2.05	0.91	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	2.30	1.75	2.30
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	2.15	2.15	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	1.72	2.37	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	1.99	0.87	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	3.43	1.20	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	2.24	2.24	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.16	18.47	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	11.69	14.28	5.63
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	2.64	18.51	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	6.35	10.23	2.12
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	14.53	7.99	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	7.34	6.64	2.45
Hepatocyte, donor1	11523-119I2	10.90	1.21	3.63
Hepatocyte, donor2	11603-120I1	26.93	1.08	0.00
Hepatocyte, donor3	11684-122I1	7.98	3.68	4.29
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	3.92	15.01	4.57
Intestinal epithelial cells (polarized), donor1	11246-116E4	8.91	5.07	2.80
Iris Pigment Epithelial Cells, donor1	11530-119I9	2.33	2.74	2.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	38.21	25.47	12.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	26.70	33.38
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	23.53	18.00	6.92
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	35.04	15.02
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	23.74	23.74
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	38.44	7.69
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	22.85	27.42
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	34.11	11.37
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	15.01	20.01	10.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	21.78	25.41
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	23.82	43.67	13.23
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	21.06	17.74	6.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	15.71	15.71
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	17.64	24.56	9.45
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	23.20	23.20	20.11
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	19.38	19.38	9.69
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	27.37	25.76	9.66
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	35.84	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	13.85	29.34	12.22
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	18.47	18.47	16.79
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.07	24.91	10.45
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	14.77	11.08	4.62
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	12.75	11.33	4.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.98	16.33	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	24.75	23.67	8.61
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	27.95	25.41	13.98
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	17.86	14.67	8.93
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	25.52	16.40	9.11
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	15.00	13.57	6.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	26.55	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.96	11.73	2.78
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	24.58	24.58	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	25.15	9.43
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	25.03	15.99	10.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	37.62	22.13	11.07
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	19.45	19.45	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	22.67	20.05	16.57
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	38.25	24.75	13.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	13.94	13.94
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	22.40	27.74	21.34
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	26.32	16.63	11.08
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	22.80	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	29.45	11.05	17.49
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	24.20	21.18	30.25
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	31.04	31.04
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	17.98	20.09	22.20
Keratinocyte - epidermal, donor1	11272-116H3	5.55	1.71	1.31
Keratinocyte - epidermal, donor2	11349-117G8	2.93	3.51	1.17
Keratinocyte - epidermal, donor3	11421-118F8	4.54	2.93	2.93
Keratinocyte - oral, donor1	11251-116E9	5.90	1.70	4.65
Keratocytes, donor1	11527-119I6	21.32	4.81	2.75
Keratocytes, donor2	11607-120I5	14.06	5.86	1.17
Keratocytes, donor3	11688-122I5	12.05	2.37	3.36
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	1.08	5.39	0.00
Lens Epithelial Cells, donor2	11609-120I7	4.38	6.92	4.27
Lens Epithelial Cells, donor3	11690-122I7	4.44	2.83	1.51
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	8.30	17.79	5.45
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	5.02	11.44	3.07
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	5.98	15.27	3.62
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	7.53	22.05	2.69
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.36	14.18	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.87	12.29	3.34
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	10.26	8.62	3.69
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.31	11.12	3.29
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	6.33	11.82	4.08
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	5.14	12.26	1.98
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	6.59	12.21	4.65
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.37	12.22	4.07
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.57	9.76	2.79
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	7.39	11.93	4.53
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5.22	12.09	3.43
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	9.85	13.24	3.70
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.61	11.22	2.81
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.95	13.54	2.56
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	6.25	14.48	1.97
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	5.27	10.54	3.81
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.72	14.44	3.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	8.73	16.00	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	3.77	9.69	2.15
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.11	13.47	3.18
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	6.74	13.48	3.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	5.65	12.35	3.98
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	8.57	11.88	4.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	9.63	24.08	5.50
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.83	13.92	3.57
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.00	13.47	4.03
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	11.63	20.84	3.88
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.93	16.54	3.31
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.54	14.00	4.21
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	8.51	18.88	4.44
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	5.68	13.59	3.21
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.15	13.61	3.85
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	8.36	12.22	2.25
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7.61	14.30	3.65
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	8.54	14.28	4.06
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	9.24	18.84	4.27
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4.36	14.54	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	9.96	15.56	3.89
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.80	17.55	2.51
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	8.17	15.68	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.36	14.60	3.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	7.67	12.75	3.59
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.68	11.78	4.10
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	7.46	14.62	2.39
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	9.06	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	6.90	6.90	3.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	4.45	8.91	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	3.81	9.73	3.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	2.11	8.44	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	4.67	6.54	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	2.58	5.15	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	1.19	7.14	4.76
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	2.04	8.14	2.71
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	2.62	6.69	2.33
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	2.70	9.90	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	2.71	8.26	4.47
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	3.59	9.24	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	2.82	6.70	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	3.33	5.33	2.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	3.06	7.64	4.08
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	4.00	4.27	2.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	4.72	8.12	2.46
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	6.14	7.98	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	3.26	9.79	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	2.50	7.91	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	3.64	6.73	3.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	6.18	10.30	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	3.19	5.52	2.03
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	2.99	5.68	2.39
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	1.66	7.19	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	2.12	7.42	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	2.95	7.74	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	2.30	8.06	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	4.22	8.44	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	3.96	10.19	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	1.64	9.03	4.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	2.71	6.78	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	2.87	10.05	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	3.73	7.47	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	4.46	8.18	2.60
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	1.29	8.18	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	4.28	10.28	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	1.67	8.66	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	2.41	15.08	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	4.98	12.09	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	3.44	6.53	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	2.15	11.27	3.76
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	4.04	8.08	3.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	3.70	10.00	2.59
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	2.33	15.12	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	2.12	15.87	6.35
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	5.20	15.61	2.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	5.81	10.18	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	3.83	8.43	4.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	3.95	6.41	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	5.65	5.65	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	8.55	10.56	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	4.96	8.56	3.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	3.44	13.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	6.23	10.69	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	3.91	8.60	3.91
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	2.64	10.56	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	3.63	11.42	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	4.81	8.75	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	6.15	8.95	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	3.97	13.25	3.09
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	4.24	6.17	4.24
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.08	8.10	3.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	3.84	5.29	2.88
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	4.77	7.55	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	3.65	6.68	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	4.84	4.84	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	3.80	7.22	2.66
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	4.65	7.23	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	3.02	4.23	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	3.49	10.14	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	4.26	11.19	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	2.87	13.22	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	3.09	5.66	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	4.24	7.78	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	2.27	10.78	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	5.41	7.07	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	6.26	7.05	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	1.67	11.27	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	3.72	10.22	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	6.02	5.35	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	1.60	10.16	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	2.42	11.72	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	1.84	11.93	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	2.67	18.67	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	2.28	15.39	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.14	7.67	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	5.47	9.30	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	1.78	9.35	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	3.38	9.10	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	2.65	9.95	3.98
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	6.24	14.55	0.00
Macrophage - monocyte derived, donor1	11232-116C8	11.40	3.42	1.14
Macrophage - monocyte derived, donor2	11313-117C8	2.57	4.04	2.39
Macrophage - monocyte derived, donor3	11389-118C3	7.73	3.80	1.05
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	5.31	2.66	0.00
Mallassez-derived cells, donor2	11929-125I3	13.63	8.08	1.11
Mallassez-derived cells, donor3	11930-125I4	7.37	4.86	1.11
Mammary Epithelial Cell, donor1	11273-116H4	3.49	0.90	1.00
Mammary Epithelial Cell, donor2	11350-117G9	3.19	2.61	1.16
Mammary Epithelial Cell, donor3	11422-118F9	4.24	1.00	0.50
Mast cell - stimulated, donor1	11487-119E2	6.78	4.07	0.68
Mast cell, donor1	11563-120D6	14.27	6.92	1.73
Mast cell, donor2	11565-120D8	56.46	11.59	4.75
Mast cell, donor3	11566-120D9	88.92	9.46	7.88
Mast cell, donor4	11567-120E1	52.65	9.57	4.61
Mast cell, expanded and stimulated, donor5	11940-126A5	17.30	11.42	4.10
Mast cell, expanded and stimulated, donor8	11942-126A7	22.18	8.76	5.25
Mast cell, expanded, donor5	11939-126A4	14.45	6.77	3.79
Mast cell, expanded, donor8	11941-126A6	35.82	11.38	3.51
Melanocyte - dark, donor1	11502-119F8	5.67	16.52	3.28
Melanocyte - dark, donor2	11582-120F7	21.46	9.34	2.08
Melanocyte - dark, donor3	11663-122F7	7.03	4.06	2.90
Melanocyte - light, donor1	11274-116H5	7.29	2.35	0.94
Melanocyte - light, donor2	11351-117H1	8.87	4.09	0.68
Melanocyte - light, donor3	11423-118G1	7.81	2.60	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	3.75	6.77	1.67
Melanocyte, donor2 (MC+2)	12739-135I3	13.45	11.56	1.34
Melanocyte, donor3 (MC+3)	12837-137B2	14.46	11.52	2.41
Meningeal Cells, donor1	11493-119E8	2.23	8.31	1.86
Meningeal Cells, donor2	11573-120E7	5.72	7.92	0.44
Meningeal Cells, donor3	11654-122E7	0.98	3.18	4.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	11.12	2.57	3.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	9.76	2.72	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	14.46	3.94	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	13.08	2.62	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	9.33	3.59	3.59
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	6.14	2.75	1.69
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	12.57	3.02	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	8.13	4.83	1.98
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.77	3.65	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	11.05	2.05	2.25
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	9.42	2.77	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	16.73	6.69	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	8.42	2.50	4.61
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	14.54	4.45	1.78
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	32.70	4.67	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	12.17	2.56	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	8.51	2.48	2.13
Mesenchymal stem cells - hepatic, donor0	11218-116B3	7.19	3.44	2.19
Mesenchymal stem cells - umbilical, donor0	11214-116A8	12.34	3.63	1.45
Mesothelial Cells, donor1	11247-116E5	15.11	9.28	1.86
Mesothelial Cells, donor2	12156-128G5	7.51	6.51	1.50
Mesothelial Cells, donor3	11402-118D7	22.69	15.90	1.37
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	2.70	2.70	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	12.81	2.46	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	9.72	3.53	2.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	9.92	2.79	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	7.05	3.53	2.28
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	11.01	3.75	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	9.31	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	8.33	4.47	1.42
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	7.92	4.75	2.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	4.42	5.31	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6.84	2.28	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	8.06	2.33	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	2.76	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	2.98	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.01	0.75	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	2.38	2.38	2.61
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1.11	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	3.45	1.61	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.68	0.84	1.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	2.85	1.63	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	6.01	1.72	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	4.45	0.67	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.48	0.88	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.06	3.04	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	4.08	1.63	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	3.23	1.76	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	0.00	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	4.81	1.44	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	5.20	2.80	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.01	3.00	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	5.26	3.07	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	2.21	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	0.00	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	7.19	4.71	2.23
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.96	3.48	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	8.84	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	9.57	7.18	3.76
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.88	4.81	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.10	3.20	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	10.66	8.42	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	12.05	7.07	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	18.65	5.83	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.75	7.54	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	16.28	6.26	2.09
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	14.78	6.46	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.94	10.24	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	13.54	6.49	0.69
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	14.77	11.66	1.81
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	18.87	9.87	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	18.42	5.72	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	16.28	8.27	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	18.26	10.48	2.69
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	10.45	4.80	0.99
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	13.70	10.83	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	21.67	11.94	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	14.03	3.79	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	15.06	10.51	3.41
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	21.38	14.99	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.69	3.91	1.96
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	13.53	7.64	2.94
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	15.86	12.69	2.02
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	5.36	7.42	2.89
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.46	7.15	2.98
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	15.77	0.99	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	6.31	2.10	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	14.63	2.17	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	16.76	5.59	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	16.52	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	15.18	7.46	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	5.88	1.47	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	10.31	2.95	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	12.09	1.47	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	10.89	6.22	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1.07	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	10.10	0.00	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.48	1.69	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	6.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	39.97	11.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	29.36	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	25.10	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	8.19	5.39	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	9.41	2.61	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	15.35	2.00	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	14.19	0.83	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	13.31	1.33	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	20.75	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	17.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	17.16	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	15.57	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	20.27	0.81	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	19.97	0.63	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	18.37	1.99	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	14.62	1.62	2.44
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.24	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	18.29	1.96	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	17.13	0.73	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	16.97	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	19.21	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	12.47	3.28	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	12.85	0.98	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	16.58	0.88	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	18.28	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	23.90	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	19.28	0.64	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	9.31	2.41	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	0.00	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	15.37	0.67	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	17.78	2.54	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	18.04	1.42	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	21.89	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	23.33	2.33	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.72	0.90	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.09	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	15.79	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	15.89	2.27	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	14.34	0.98	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	11.77	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	10.85	1.36	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	17.64	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	19.95	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	22.82	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	19.91	1.15	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.38	5.44	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	10.39	2.65	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	15.59	2.71	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	18.90	2.44	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	19.51	1.89	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	15.44	0.91	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	17.41	1.58	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	9.07	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	5.06
Myoblast, donor1	11241-116D8	8.57	2.48	0.25
Myoblast, donor2	11322-117D8	16.11	1.15	0.19
Myoblast, donor3	11398-118D3	10.76	1.35	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	20.87	2.63	3.06
Natural Killer Cells, donor1	11230-116C6	62.43	6.15	7.69
Natural Killer Cells, donor2	11311-117C6	76.29	2.71	8.75
Natural Killer Cells, donor3	11387-118C1	71.78	4.05	6.81
Neural stem cells, donor1	11275-116H6	10.89	6.90	5.44
Neural stem cells, donor2	11352-117H2	13.48	32.74	13.48
Neurons, donor1	11494-119E9	20.48	63.72	11.38
Neurons, donor2	11574-120E8	11.01	37.43	18.49
Neurons, donor3	11655-122E8	18.09	29.60	11.51
Neutrophils, donor1	11233-116C9	30.62	12.99	7.42
Neutrophils, donor2	11314-117C9	23.19	5.80	5.80
Neutrophils, donor3	11390-118C4	39.70	24.43	13.44
Nucleus Pulposus Cell, donor1	11252-116F1	15.20	2.14	2.02
Nucleus Pulposus Cell, donor2	11409-118E5	22.79	1.30	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	9.83	2.01	0.80
Olfactory epithelial cells, donor1	11933-125I7	18.72	1.93	0.28
Olfactory epithelial cells, donor2	11934-125I8	12.74	0.43	0.72
Olfactory epithelial cells, donor3	11935-125I9	13.73	1.25	0.68
Olfactory epithelial cells, donor4	11936-126A1	13.34	1.66	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	7.22	4.21	3.01
Osteoblast - differentiated, donor1	11276-116H7	1.91	3.19	1.06
Osteoblast - differentiated, donor2	11353-117H3	10.29	4.57	3.43
Osteoblast - differentiated, donor3	11425-118G3	21.10	0.62	0.00
Osteoblast, donor1	11277-116H8	17.39	7.23	6.64
Osteoblast, donor2	11354-117H4	9.13	0.70	2.81
Osteoblast, donor3	11426-118G4	15.28	3.38	1.96
Pancreatic stromal cells, donor1	11249-116E7	10.28	1.52	1.43
Pericytes, donor1	11491-119E6	8.57	4.34	1.56
Pericytes, donor2	11571-120E5	14.94	9.51	1.13
Pericytes, donor3	11652-122E5	10.17	9.36	2.85
Perineurial Cells, donor1	11499-119F5	5.09	3.73	3.05
Perineurial Cells, donor2	11579-120F4	17.57	7.73	2.85
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	45.26	6.06	7.97
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	41.14	3.43	6.37
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	50.47	4.79	7.64
Placental Epithelial Cells, donor1	11278-116H9	8.13	10.28	1.91
Placental Epithelial Cells, donor2	11355-117H5	21.07	8.87	2.22
Placental Epithelial Cells, donor3	11427-118G5	14.92	4.12	1.18
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	15.19	3.48	0.95
Preadipocyte - breast, donor1	11467-119B9	12.01	2.06	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	16.05	5.74	1.83
Preadipocyte - breast, donor2	11328-117E5	15.31	4.05	1.13
Preadipocyte - omental, donor1	11468-119C1	6.82	1.81	0.64
Preadipocyte - omental, donor2	11329-117E6	9.17	1.75	0.44
Preadipocyte - omental, donor3	11403-118D8	14.18	2.72	0.57
Preadipocyte - perirenal, donor1	11469-119C2	13.78	4.92	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	21.50	3.38	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	18.06	3.72	2.30
Preadipocyte - subcutaneous, donor3	11428-118G6	21.80	2.38	1.19
Preadipocyte - visceral, donor1	11280-116I2	13.97	2.05	1.68
Preadipocyte - visceral, donor2	11357-117H7	21.17	5.06	0.00
Preadipocyte - visceral, donor3	11429-118G7	15.26	2.30	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	5.58	7.69	2.72
Prostate Epithelial Cells, donor2	11331-117E8	13.68	5.15	1.08
Prostate Epithelial Cells, donor3	11404-118D9	2.08	2.82	3.49
Prostate Stromal Cells, donor1	11254-116F3	13.21	4.10	2.51
Prostate Stromal Cells, donor2	11332-117E9	18.65	5.38	1.26
Prostate Stromal Cells, donor3	11405-118E1	21.69	4.07	1.88
Renal Cortical Epithelial Cells, donor1	11516-119H4	4.01	4.74	4.74
Renal Cortical Epithelial Cells, donor2	11596-120H3	1.39	5.61	7.07
Renal Epithelial Cells, donor1	11517-119H5	3.55	7.61	7.61
Renal Epithelial Cells, donor2	11597-120H4	4.98	7.11	2.85
Renal Epithelial Cells, donor3	11678-122H4	2.22	8.68	8.26
Renal Glomerular Endothelial Cells, donor1	11514-119H2	11.57	25.87	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	10.65	14.02	1.35
Renal Glomerular Endothelial Cells, donor3	11675-122H1	6.22	7.55	4.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.99	21.29	7.99
Renal Mesangial Cells, donor1	11518-119H6	7.48	7.48	3.74
Renal Mesangial Cells, donor2	11598-120H5	6.90	3.76	3.13
Renal Mesangial Cells, donor3	11679-122H5	8.88	11.65	4.72
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	2.95	4.03	2.42
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	3.37	3.37	4.22
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	3.09	7.91	4.63
Retinal Pigment Epithelial Cells, donor0	11215-116A9	2.33	2.33	3.89
Retinal Pigment Epithelial Cells, donor1	11528-119I7	7.96	7.39	2.56
Retinal Pigment Epithelial Cells, donor2	11608-120I6	3.09	6.17	3.09
Retinal Pigment Epithelial Cells, donor3	11689-122I6	3.76	3.76	4.77
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	13.50	7.88	3.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	5.36	9.83	6.25
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	0.00	14.31	3.30
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	1.16	8.12	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	1.30	4.03	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	2.98	2.38	2.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	2.34	3.79	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	2.23	2.98	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	2.33	2.68	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	5.08	4.39	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	1.23	3.56	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	1.97	2.27	3.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	3.76	4.30	2.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	3.01	4.73	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	2.68	2.36	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	2.21	3.32	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	2.68	3.06	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	2.05	2.70	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	2.44	4.70	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	2.12	2.79	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	2.34	2.73	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	2.29	2.48	2.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	2.24	3.42	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	2.24	2.24	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	3.59	2.73	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	1.82	2.92	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	1.84	2.94	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	2.69	3.09	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	2.59	5.66	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	1.98	2.58	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	3.27	3.51	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	1.66	5.60	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	2.65	1.11	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	1.25	3.55	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	3.36	4.71	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	2.55	2.21	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	4.24	3.66	1.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	2.24	5.85	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	3.84	3.29	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	3.61	2.79	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	2.22	4.26	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	2.22	3.40	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	2.13	3.20	2.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	3.32	6.64	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	2.86	3.81	3.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	5.24	7.26	4.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	3.11	4.71	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	2.79	5.24	3.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	2.72	4.53	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	2.81	4.41	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	8.59	11.21	8.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	6.08	5.48	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	3.62	5.43	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	4.07	9.05	4.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	5.99	7.79	5.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	2.60	11.45	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	4.70	8.75	4.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	5.41	8.41	6.61
Schwann Cells, donor1	11498-119F4	8.84	8.46	1.69
Schwann Cells, donor2	11578-120F3	3.40	3.40	3.40
Schwann Cells, donor3	11659-122F3	10.08	6.79	1.53
Sebocyte, donor1	11220-116B5	8.22	3.29	1.10
Sebocyte, donor2	11301-117B5	9.65	3.22	1.84
Sebocyte, donor3	11378-118B1	8.24	0.82	1.24
Sertoli Cells, donor1	11255-116F4	6.63	3.31	1.66
Sertoli Cells, donor2	11333-117F1	8.47	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	22.17	6.51	2.90
Skeletal Muscle Cells, donor2	11358-117H8	18.79	5.06	0.72
Skeletal Muscle Cells, donor3	11430-118G8	31.77	11.70	2.51
Skeletal Muscle Cells, donor4	11451-119A2	9.58	4.40	1.26
Skeletal Muscle Cells, donor5	11455-119A6	8.47	4.01	1.04
Skeletal Muscle Cells, donor6	11459-119B1	5.39	6.46	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	16.25	5.80	2.02
Skeletal Muscle Satellite Cells, donor2	11321-117D7	12.98	4.42	2.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	10.52	6.45	3.27
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	15.17	6.91	2.44
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	20.99	7.96	4.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	19.13	2.34	0.69
Skin - palm, donor1	10286-104F7	32.23	8.06	8.06
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	18.31	3.60	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	79.34	49.89	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	10.52	1.56	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	6.81	3.89	1.95
Small Airway Epithelial Cells, donor2	11334-117F2	10.41	3.80	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	39.96	10.57	1.90
Small Airway Epithelial Cells, donor3	11406-118E2	7.87	2.77	1.87
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	14.50	4.01	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	19.79	11.56	2.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	24.69	6.47	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	11.49	5.52	2.21
Smooth Muscle Cells - Aortic, donor2	11360-117I1	23.23	7.09	2.76
Smooth Muscle Cells - Aortic, donor3	11432-118H1	20.86	5.41	3.09
Smooth Muscle Cells - Bladder, donor1	11519-119H7	30.02	6.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	17.57	6.25	1.86
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	13.30	2.66	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	18.95	5.12	1.02
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	3.58	3.26	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	7.38	3.84	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	10.53	8.11	2.70
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	9.44	3.42	1.30
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	14.00	2.13	2.13
Smooth Muscle Cells - Carotid, donor1	11285-116I7	11.62	1.77	2.53
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	15.74	8.11	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	6.34	2.95	2.21
Smooth Muscle Cells - Colonic, donor2	11320-117D6	10.12	4.09	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	12.39	3.25	1.68
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	20.73	7.12	1.70
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	18.32	4.31	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	23.01	8.67	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	8.88	7.51	2.05
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	13.59	6.28	5.42
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	7.35	1.51	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	40.50	9.10	2.50
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	16.91	9.06	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	4.24	4.77	2.12
Smooth Muscle Cells - Prostate, donor1	11257-116F6	11.32	4.39	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	19.28	5.13	2.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	10.91	1.27	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	10.10	6.18	2.26
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	24.01	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	14.21	10.34	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	16.28	5.58	4.65
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	39.38	9.09	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	18.49	3.45	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.60	1.47	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	5.66	1.33	1.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	19.62	0.93	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	14.10	4.75	2.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	20.14	4.59	2.55
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	16.55	3.95	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	7.55	3.63	2.38
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	6.87	5.95	2.77
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	22.38	3.81	5.71
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	13.95	4.65	1.71
Smooth Muscle Cells - Uterine, donor1	11258-116F7	9.72	3.98	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	7.02	3.80	2.34
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	20.60	3.50	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.02	1.85	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	10.04	2.60	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	16.17	5.39	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	16.18	2.27	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	11.42	1.97	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	16.25	3.30	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	15.97	5.59	3.19
Smooth muscle cells - airway, control, donor3	11968-126D6	16.72	2.09	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	24.29	4.13	1.38
Synoviocyte, donor1	11291-117A4	6.23	1.01	1.18
Synoviocyte, donor2	11368-117I9	17.60	1.34	1.01
Synoviocyte, donor3	11440-118H9	15.64	0.45	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	13.94	4.65	1.43
Trabecular Meshwork Cells, donor2	11612-122A1	21.80	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	18.52	4.63	5.09
Tracheal Epithelial Cells, donor1	11292-117A5	3.87	2.29	1.94
Tracheal Epithelial Cells, donor2	11369-118A1	12.37	4.25	2.71
Tracheal Epithelial Cells, donor3	11441-118I1	14.32	4.01	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	12.30	6.77	3.81
Urethra, donor2	10319-105A4	35.97	1.80	1.80
Urothelial Cells, donor1	11520-119H8	14.08	16.21	2.92
Urothelial Cells, donor2	11600-120H7	18.43	8.81	2.40
Urothelial Cells, donor3	11681-122H7	14.44	9.63	4.13
Urothelial cells, donor0	11216-116B1	14.27	11.81	9.14
Whole blood (ribopure), donor090309, donation1	12179-129A1	31.14	20.47	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	28.59	18.58	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	30.12	15.06	9.58
Whole blood (ribopure), donor090325, donation1	12176-128I7	25.83	14.12	11.36
Whole blood (ribopure), donor090325, donation2	12177-128I8	23.24	9.88	5.23
Whole blood (ribopure), donor090612, donation1	12182-129A4	17.70	18.74	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	17.44	24.78	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	25.56	17.35	7.30
Wilms' tumor cell line:G-401	10809-111A8	4.81	3.21	2.71
Wilms' tumor cell line:HFWT	10597-108E3	0.00	4.40	3.52
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	5.03	1.68	2.51
achilles tendon, donor2	10292-104G4	45.46	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	3.31	4.84	2.80
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	8.13	7.66	5.34
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	2.61	7.00	4.87
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	5.44	10.88	4.35
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	2.25	16.30	7.87
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	7.19	10.79	5.71
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	7.08	15.79	2.72
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	8.37	2.64	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	13.48	11.43	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	20.19	6.60	2.72
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	1.84	2.39	3.13
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	3.90	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	5.81	9.06	6.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	10.36	6.73	3.62
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	5.84	3.21	4.68
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	10.69	2.79	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	14.39	2.06	2.06
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.61	1.53	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	0.00	1.28	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	0.30	0.91	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	0.24	1.68	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	5.79	5.57	3.12
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	4.34	11.01	1.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	9.29	7.43	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	3.01	6.40	2.26
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	9.16	23.55	6.98
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	28.12	16.87	1.87
adenocarcinoma cell line:IM95m	10796-110I4	7.77	2.12	2.12
adipose tissue, adult, pool1	10010-101C1	10.39	8.84	4.19
adipose, donor1	10184-103D4	7.62	21.11	24.63
adipose, donor2	10185-103D5	14.19	8.52	14.60
adipose, donor3	10186-103D6	10.62	12.53	9.53
adipose, donor4	10187-103D7	2.60	13.87	7.80
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	0.95	3.31	4.89
adrenal gland, adult, pool1	10081-102A9	21.83	3.64	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	30.42	2.00	6.54
alveolar cell carcinoma cell line:SW 1573	10708-109H6	7.15	3.22	1.43
amniotic membrane cells, donor1	12235-129G3	8.11	4.41	2.09
amniotic membrane cells, donor2	12236-129G4	5.41	1.69	2.03
amniotic membrane cells, donor3	12237-129G5	7.37	4.42	2.65
amygdala - adult, donor10196	10167-103B5	5.93	3.56	4.74
amygdala, adult, donor10252	10151-102I7	7.91	13.38	9.33
amygdala, newborn, donor10223	10360-105E9	15.17	16.78	2.90
anaplastic carcinoma cell line:8305C	10428-106D5	16.17	3.57	3.31
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	1.76	4.85	5.74
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	7.68	8.35	15.03
aorta, adult, pool1	10052-101G7	20.01	5.10	7.26
appendix, adult	10189-103D9	24.45	8.54	4.66
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	11.01	5.85	5.50
artery, adult	10190-103E1	16.30	2.72	4.08
astrocytoma cell line:TM-31	10425-106D2	8.84	2.90	2.75
b cell line:RPMI1788	10427-106D4	6.54	7.14	5.95
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.99	3.88	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	7.34	3.37	3.47
bile duct carcinoma cell line:TFK-1	10496-107C1	1.00	1.67	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	10.63	5.03	3.36
bladder, adult, pool1	10011-101C2	13.25	5.54	8.58
blood, adult, pool1	10053-101G8	19.93	4.43	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	15.41	0.86	0.86
bone marrow, adult	10192-103E3	8.10	4.72	4.72
brain, adult, donor1	10084-102B3	4.10	6.15	7.18
brain, adult, pool1	10012-101C3	5.68	3.23	7.91
brain, fetal, pool1	10085-102B4	13.36	42.74	24.04
breast carcinoma cell line:MCF7	10482-107A5	6.61	3.30	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	8.36	1.50	1.12
breast, adult, donor1	10080-102A8	17.05	6.31	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	3.56	1.40	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	6.80	1.86	3.40
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	1.61	6.45	9.21
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	2.91	1.94	1.21
carcinoid cell line:NCI-H1770	10703-109H1	0.94	3.76	3.76
carcinoid cell line:NCI-H727	10735-110B6	3.39	4.92	3.28
carcinoid cell line:SK-PN-DW	10719-109I8	2.22	1.90	7.61
carcinosarcoma cell line:JHUCS-1	10642-109A3	16.50	6.92	5.59
caudate nucleus - adult, donor10196	10177-103C6	13.82	1.15	11.51
caudate nucleus, adult, donor10252	10164-103B2	12.38	11.04	11.21
caudate nucleus, adult, donor10258	10379-105H1	12.23	3.06	3.82
caudate nucleus, newborn, donor10223	10354-105E3	19.41	17.21	5.13
cerebellum - adult, donor10196	10173-103C2	26.22	5.83	32.05
cerebellum, adult, donor10252	10166-103B4	53.59	14.52	30.96
cerebellum, adult, pool1	10083-102B2	20.70	5.52	11.04
cerebellum, newborn, donor10223	10357-105E6	95.48	65.59	10.79
cerebral meninges, adult	10188-103D8	7.56	4.03	5.29
cerebrospinal fluid, donor2	10294-104G6	8.77	2.19	2.19
cervical cancer cell line:D98-AH2	10552-107I3	4.46	0.58	3.45
cervical cancer cell line:ME-180	10553-107I4	7.62	1.99	1.33
cervix, adult, pool1	10013-101C4	22.05	9.34	9.24
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	4.60	1.11	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	7.84	5.23	1.31
choriocarcinoma cell line:BeWo	10423-106C9	6.96	14.42	12.43
choriocarcinoma cell line:SCH	10785-110H2	4.44	14.17	2.34
choriocarcinoma cell line:T3M-3	10618-108G6	2.37	19.69	4.51
chorionic membrane cells, donor1	12238-129G6	8.55	8.26	3.13
chorionic membrane cells, donor2	12239-129G7	14.91	10.44	2.39
chorionic membrane cells, donor3	12240-129G8	12.09	10.44	3.30
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	6.06	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	6.72	4.80	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	12.25	12.46	2.11
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	6.68	4.62	4.11
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	6.05	3.87	6.29
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	6.31	5.29	4.89
chronic myelogenous leukemia cell line:K562	10454-106G4	6.48	2.65	3.53
chronic myelogenous leukemia cell line:KU812	10409-106B4	8.60	7.30	2.09
clear cell carcinoma cell line:JHOC-5	10638-108I8	1.14	2.29	5.94
clear cell carcinoma cell line:TEN	10636-108I6	1.56	1.39	1.91
colon carcinoma cell line:CACO-2	10513-107D9	2.75	7.32	4.76
colon carcinoma cell line:COLO-320	10420-106C6	8.36	4.18	12.16
colon, adult, donor1	10082-102B1	30.94	5.95	4.76
colon, adult, pool1	10014-101C5	27.38	8.93	5.41
colon, fetal, donor1	10070-101I7	25.96	6.18	6.80
common myeloid progenitor CMP, donor1	12130-128D6	50.42	55.00	18.33
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	7.65	7.65	5.95
cord blood derived cell line:COBL-a 24h infection	10453-106G3	4.38	4.23	3.32
cord blood derived cell line:COBL-a untreated	10449-106F8	4.94	5.36	3.38
corpus callosum, adult, pool1	10042-101F6	9.73	13.93	7.85
cruciate ligament, donor2	10295-104G7	29.99	6.48	4.86
diaphragm, fetal, donor1	10069-101I6	20.06	8.83	0.80
diencephalon, adult	10193-103E4	4.80	2.40	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	9.64	4.59	3.67
ductal cell carcinoma cell line:KLM-1	10438-106E6	4.36	5.90	3.08
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	6.02	2.17	0.72
ductus deferens, adult	10196-103E7	33.39	7.48	4.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	23.04	7.20	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	25.75	12.51	5.89
dura mater, adult, donor1	10041-101F5	14.21	3.88	9.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	13.32	34.20	9.99
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	3.44	11.75	7.88
embryonic pancreas cell line:1B2C6	10604-108F1	9.25	3.08	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	6.96	3.63	4.54
embryonic pancreas cell line:1C3IKEI	10606-108F3	10.81	4.32	0.62
embryonic pancreas cell line:2C6	10603-108E9	5.25	6.57	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	4.69	6.03	4.02
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	6.71	5.62	9.97
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	1.93	7.08	2.09
epidermoid carcinoma cell line:A431	10426-106D3	7.67	1.33	1.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	7.59	3.52	0.55
epididymis, adult	10197-103E8	27.21	9.84	9.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	1.95	1.42	2.31
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	0.39	2.75	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	4.98	1.44	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	5.22	1.57	2.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	4.26	2.69	1.46
esophagus, adult, pool1	10015-101C6	8.81	5.63	3.50
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	0.38	5.51	9.64
eye - muscle inferior rectus, donor1	10272-104E2	50.71	7.24	7.24
eye - muscle lateral, donor2	10298-104H1	14.73	4.21	0.00
eye - muscle medial, donor2	10299-104H2	25.30	2.98	0.00
eye - muscle superior, donor2	10297-104G9	28.66	9.17	3.44
eye - vitreous humor, donor1	10268-104D7	13.12	5.83	4.37
eye, fetal, donor1	10054-101G9	13.73	7.88	8.90
fibrosarcoma cell line:HT-1080	10758-110E2	5.77	4.23	2.05
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	9.73	2.14	0.95
frontal lobe, adult, pool1	10040-101F4	8.16	5.44	9.95
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	1.50	3.60	4.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	2.01	2.10	7.86
gall bladder, adult	10198-103E9	17.62	6.04	3.14
gamma delta positive T cells, donor1	11937-126A2	36.51	11.81	9.66
gamma delta positive T cells, donor2	11938-126A3	38.47	6.35	7.84
gastric adenocarcinoma cell line:MKN1	10614-108G2	11.41	4.01	2.11
gastric adenocarcinoma cell line:MKN45	10612-108F9	2.51	3.09	3.48
gastric cancer cell line:AZ521	10549-107H9	0.49	3.77	3.44
gastric cancer cell line:GSS	10560-108A2	0.92	9.15	9.15
gastrointestinal carcinoma cell line:ECC12	10615-108G3	10.74	10.05	2.28
giant cell carcinoma cell line:LU65	10487-107B1	1.38	0.46	1.72
giant cell carcinoma cell line:Lu99B	10433-106E1	6.72	4.48	3.08
glassy cell carcinoma cell line:HOKUG	10688-109F4	4.24	1.75	2.24
glioblastoma cell line:A172, tech_rep1	10444-106F3	4.64	2.96	2.96
glioblastoma cell line:A172, tech_rep2	10444-106F3	4.49	1.69	3.79
glioblastoma cell line:T98G	10485-107A8	4.30	1.32	2.21
glioma cell line:GI-1	10413-106B8	6.44	4.39	2.93
globus pallidus - adult, donor10196	10175-103C4	9.48	6.56	8.02
globus pallidus, adult, donor10252	10161-103A8	16.60	13.18	7.57
globus pallidus, adult, donor10258	10367-105F7	8.22	13.69	8.22
globus pallidus, newborn, donor10223	10364-105F4	13.32	14.39	4.80
granulocyte macrophage progenitor, donor1	12131-128D7	29.37	29.37	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	9.28	5.12	2.24
hIPS +CCl2, biol_rep1	14383-156B9	4.13	9.18	3.67
hIPS +CCl2, biol_rep2	14384-156C1	3.66	7.77	5.03
hIPS +CCl2, biol_rep3	14385-156C2	7.73	9.66	3.86
hIPS, biol_rep1	14380-156B6	2.87	10.06	4.31
hIPS, biol_rep2	14381-156B7	7.54	8.23	3.43
hIPS, biol_rep3	14382-156B8	7.72	7.72	9.93
hairy cell leukemia cell line:Mo	10712-109I1	9.19	8.05	5.75
heart - mitral valve, adult	10205-103F7	24.81	12.26	2.69
heart - pulmonic valve, adult	10206-103F8	14.64	5.23	3.66
heart - tricuspid valve, adult	10207-103F9	26.64	13.32	3.33
heart, adult, diseased post-infarction, donor1	10050-101G5	7.96	7.55	3.06
heart, adult, diseased, donor1	10051-101G6	12.77	7.24	5.11
heart, adult, pool1	10016-101C7	6.67	5.98	2.99
heart, fetal, pool1	10046-101G1	14.68	12.42	6.67
hepatic mesenchymal tumor cell line:LI90	10778-110G4	14.19	3.39	4.32
hepatoblastoma cell line:HuH-6	10633-108I3	2.38	5.95	5.95
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	3.09	4.20	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	1.94	2.67	1.70
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	2.63	3.64	1.72
hepatoma cell line:Li-7	10484-107A7	10.23	5.23	3.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	5.33	4.02	4.32
hippocampus - adult, donor10196	10169-103B7	14.19	9.46	7.57
hippocampus, adult, donor10252	10153-102I9	10.41	13.06	8.37
hippocampus, adult, donor10258	10374-105G5	5.98	6.97	3.49
hippocampus, newborn, donor10223	10363-105F3	14.45	14.80	4.58
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	5.49	19.53	17.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	4.71	13.74	11.78
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	3.05	14.47	16.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	11.84	7.33	20.30
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	7.23	7.23	25.05
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	9.87	11.77	31.13
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	21.31	18.69	22.48
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	10.56	17.88	28.44
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	20.85	20.44	17.10
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	12.55	15.87	8.52
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	13.50	15.27	11.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	13.47	13.47	10.77
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	2.82	13.14	9.55
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	3.93	12.28	7.86
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	0.87	17.46	15.71
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	12.03	10.88	19.66
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	10.03	14.83	13.08
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	18.49	22.49	15.99
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	10.36	10.93	32.78
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	13.19	15.46	26.37
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	14.41	14.72	23.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	13.55	10.94	6.53
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	11.32	12.19	8.71
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	16.44	16.74	12.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	5.36	16.63	10.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	5.42	14.26	8.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	7.35	19.19	14.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	15.84	20.42	15.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	9.82	18.69	12.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	11.80	23.30	27.84
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	22.75	27.92	16.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	15.94	16.60	15.94
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	20.01	16.16	17.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	18.92	18.66	8.44
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	23.47	24.99	7.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	22.85	15.79	6.05
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	6.28	14.97	8.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	7.58	16.94	12.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	4.39	11.22	14.15
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	12.84	18.34	20.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	6.51	42.29	61.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	11.91	22.17	35.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	15.32	25.72	26.82
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	14.84	22.80	24.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	15.66	17.44	31.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	9.55	17.90	7.16
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	11.78	23.43	14.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	9.43	11.05	10.78
immature langerhans cells, donor1	11904-125F5	16.47	11.14	2.18
immature langerhans cells, donor2	11905-125F6	26.14	15.05	9.51
insula, adult, pool1	10039-101F3	7.38	9.08	12.49
keratoacanthoma cell line:HKA-1	10791-110H8	16.58	3.25	3.25
kidney, adult, pool1	10017-101C8	9.01	3.20	3.40
kidney, fetal, pool1	10045-101F9	13.30	15.99	8.13
large cell lung carcinoma cell line:IA-LM	10509-107D5	13.78	7.67	3.41
large cell lung carcinoma cell line:NCI-H460	10839-111E2	4.56	3.46	3.73
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	5.32	1.10	1.10
left atrium, adult, donor1	10079-102A7	8.72	1.09	1.63
left ventricle, adult, donor1	10078-102A6	7.58	4.05	1.01
leiomyoblastoma cell line:G-402	10721-110A1	3.28	2.46	2.46
leiomyoma cell line:10964C	10569-108B2	15.09	4.67	1.44
leiomyoma cell line:15242A	10570-108B3	15.76	3.26	0.54
leiomyoma cell line:15425	10571-108B4	13.11	2.43	2.19
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	23.00	4.18	5.23
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	8.38	9.09	4.49
liposarcoma cell line:KMLS-1	10782-110G8	29.84	6.25	2.97
liposarcoma cell line:SW 872	10726-110A6	7.80	3.17	2.44
liver, adult, pool1	10018-101C9	9.40	1.13	1.13
liver, fetal, pool1	10086-102B5	6.58	9.41	0.94
locus coeruleus - adult, donor10196	10182-103D2	8.31	8.17	4.81
locus coeruleus, adult, donor10252	10165-103B3	11.26	15.69	4.43
locus coeruleus, adult, donor10258	10375-105G6	9.03	9.31	5.64
locus coeruleus, newborn, donor10223	10362-105F2	7.15	16.40	3.36
lung adenocarcinoma cell line:A549	10499-107C4	3.88	1.66	1.94
lung adenocarcinoma cell line:PC-14	10408-106B3	11.72	2.07	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	8.70	2.77	4.22
lung, adult, pool1	10019-101D1	8.51	5.08	6.14
lung, fetal, donor1	10068-101I5	23.12	22.26	2.28
lung, right lower lobe, adult, donor1	10075-102A3	18.79	5.04	3.67
lymph node, adult, donor1	10077-102A5	17.99	2.84	4.73
lymphangiectasia cell line:DS-1	10727-110A7	13.59	2.85	6.79
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	4.53	0.60	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	10.19	0.85	0.85
mature adipocyte, donor1	12231-129F8	8.44	7.10	4.00
mature adipocyte, donor2	12232-129F9	8.72	13.90	2.70
mature adipocyte, donor3	12233-129G1	6.64	7.59	0.95
mature adipocyte, donor4	12234-129G2	4.21	2.90	2.37
maxillary sinus tumor cell line:HSQ-89	10414-106B9	3.34	3.34	5.48
medial frontal gyrus - adult, donor10196	10170-103B8	3.38	3.38	6.77
medial frontal gyrus, adult, donor10252	10150-102I6	12.87	8.09	7.72
medial frontal gyrus, adult, donor10258	10368-105F8	6.35	4.13	3.49
medial frontal gyrus, newborn, donor10223	10352-105E1	13.65	46.49	12.37
medial temporal gyrus - adult, donor10196	10183-103D3	6.24	4.89	8.94
medial temporal gyrus, adult, donor10252	10156-103A3	14.01	10.40	10.19
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	17.34	5.78
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	14.35	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	22.25	29.07	12.92
medulla oblongata - adult, donor10196	10174-103C3	8.44	2.60	7.14
medulla oblongata, adult, donor10252	10155-103A2	12.23	12.38	6.50
medulla oblongata, adult, pool1	10038-101F2	8.24	9.14	8.65
medulla oblongata, newborn, donor10223	10361-105F1	12.85	10.76	3.47
medulloblastoma cell line:D283 Med	10838-111E1	1.11	6.64	12.18
medulloblastoma cell line:ONS-76	10759-110E3	4.89	2.32	1.22
melanoma cell line:COLO 679	10514-107E1	3.88	7.76	2.16
melanoma cell line:G-361	10465-106H6	3.26	3.80	5.16
meningioma cell line:HKBMM	10691-109F7	13.03	11.22	6.15
merkel cell carcinoma cell line:MKL-1	10843-111E6	9.69	12.34	7.05
merkel cell carcinoma cell line:MS-1	10844-111E7	8.30	26.18	9.33
mesenchymal precursor cell - adipose, donor1	11747-123G1	18.41	1.23	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	17.27	2.54	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	16.15	2.90	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	6.32	1.83	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	8.09	1.16	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	18.05	5.55	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	9.95	3.60	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	10.12	4.14	1.61
mesenchymal precursor cell - cardiac, donor3	11754-123G8	12.87	1.86	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.29	3.11	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	9.10	4.13	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	12.19	2.63	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	10.24	3.46	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	9.08	2.44	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	6.94	5.51	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.74	7.19	2.88
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	8.59	7.03	1.66
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.52	10.03	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	1.68	6.29	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	8.52	2.69	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	9.80	5.69	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	15.46	4.05	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	10.30	6.30	3.15
mesenchymal stem cell line:Hu5/E18	10568-108B1	13.47	3.37	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	21.46	4.57	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	20.21	2.56	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	23.56	4.19	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	22.18	2.46	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	24.71	2.82	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	19.97	4.06	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	16.90	5.11	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	21.78	5.10	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	27.40	5.48	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	20.97	2.45	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	24.04	2.16	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	19.07	2.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	21.82	4.36	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	17.19	2.46	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	21.91	5.15	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	8.20	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	18.19	2.27	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	20.37	5.82	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	23.46	2.67	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	10.63	3.27	3.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	19.05	2.33	2.33
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	25.18	6.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	17.88	2.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	23.72	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	13.40	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	13.30	0.63	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	24.49	0.69	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	3.44	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	20.78	2.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	25.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	21.22	2.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	13.71	2.81	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	21.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	4.73	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	8.26	4.13	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	5.94	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	11.45	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	5.24	2.01	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	12.14	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	12.36	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	9.33	1.98	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	12.01	1.62	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	10.19	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	8.51	6.19	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	1.65	3.54	3.54
mesothelioma cell line:ACC-MESO-4	10494-107B8	1.62	4.63	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	6.37	4.32	1.95
mesothelioma cell line:Mero-25	10850-111F4	2.95	7.04	3.18
mesothelioma cell line:Mero-41	10851-111F5	3.67	3.18	1.71
mesothelioma cell line:Mero-48a	10852-111F6	7.97	1.99	1.55
mesothelioma cell line:Mero-82	10853-111F7	14.45	2.89	0.26
mesothelioma cell line:Mero-83	10854-111F8	4.60	1.02	0.34
mesothelioma cell line:Mero-84	10855-111F9	0.76	4.04	0.51
mesothelioma cell line:Mero-95	10856-111G1	9.73	5.80	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	6.46	6.79	2.65
mesothelioma cell line:NCI-H226	10846-111E9	2.90	2.71	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	3.25	2.39	0.68
mesothelioma cell line:NCI-H28	10845-111E8	1.78	1.53	3.05
mesothelioma cell line:No36	10857-111G2	0.98	1.63	1.30
mesothelioma cell line:ONE58	10858-111G3	8.40	4.34	1.35
migratory langerhans cells, donor1	11901-125F2	4.03	18.42	12.09
migratory langerhans cells, donor2	11902-125F3	6.96	24.42	9.65
migratory langerhans cells, donor3	11903-125F4	11.85	22.26	10.77
mixed mullerian tumor cell line:HTMMT	10689-109F5	4.24	2.61	2.29
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	4.24	1.70	3.81
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	7.14	4.15	1.61
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	7.42	3.62	3.62
myelodysplastic syndrome cell line:SKM-1	10772-110F7	4.07	5.36	3.51
myeloma cell line:PCM6	10474-106I6	5.93	1.58	1.58
myxofibrosarcoma cell line:MFH-ino	10600-108E6	9.64	1.01	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	15.89	2.16	1.37
nasal epithelial cells, donor1, tech_rep1	12226-129F3	2.90	2.67	4.35
nasal epithelial cells, donor1, tech_rep2	12226-129F3	2.94	3.09	4.12
nasal epithelial cells, donor2	12227-129F4	4.42	1.66	1.10
neuroblastoma cell line:CHP-134	10508-107D4	14.72	6.21	10.81
neuroblastoma cell line:NB-1	10539-107G8	5.80	2.62	3.18
neuroblastoma cell line:NBsusSR	10607-108F4	2.95	6.33	8.44
neuroblastoma cell line:NH-12	10555-107I6	9.32	6.89	10.99
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	4.03	18.50	5.46
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	17.42	10.77	6.34
neuroectodermal tumor cell line:TASK1	10774-110F9	5.64	5.03	2.62
neuroepithelioma cell line:SK-N-MC	10728-110A8	1.91	3.81	3.81
neurofibroma cell line:Hs 53.T	10729-110A9	21.83	4.52	0.53
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	6.09	40.59	26.21
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	5.60	9.61	8.81
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	15.39	4.17	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	21.55	4.20	1.58
nucleus accumbens, adult, pool1	10037-101F1	7.12	7.69	10.87
occipital cortex - adult, donor10196	10172-103C1	8.24	4.12	8.24
occipital cortex, adult, donor10252	10163-103B1	25.76	11.27	10.47
occipital cortex, newborn, donor10223	10355-105E4	18.93	27.66	7.28
occipital lobe, adult, donor1	10076-102A4	9.18	3.41	4.20
occipital lobe, fetal, donor1	10073-102A1	16.73	55.78	17.59
occipital pole, adult, pool1	10036-101E9	6.94	4.65	9.78
olfactory region, adult	10195-103E6	6.11	6.88	8.79
optic nerve, donor1	10277-104E7	16.01	8.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	5.01	3.08	1.94
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	2.06	0.82	2.61
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	9.99	2.54	1.69
oral squamous cell carcinoma cell line:SAS	10544-107H4	11.55	1.50	1.62
osteoclastoma cell line:Hs 706.T	10704-109H2	17.64	4.12	2.65
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	4.67	1.87	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	8.27	2.97	1.27
ovary, adult, pool1	10020-101D2	6.81	11.18	6.90
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	6.23	4.22	2.57
pancreas, adult, donor1	10049-101G4	10.35	4.70	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	3.35	7.83	2.52
papillary adenocarcinoma cell line:8505C	10437-106E5	10.73	2.21	2.56
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	12.75	3.31	3.48
paracentral gyrus, adult, pool1	10035-101E8	7.41	5.77	8.24
parietal cortex, adult, donor10258	10373-105G4	3.67	2.94	1.47
parietal lobe - adult, donor10196	10171-103B9	2.82	12.23	9.40
parietal lobe, adult, donor10252	10157-103A4	10.55	12.26	10.55
parietal lobe, adult, pool1	10034-101E7	5.73	8.46	8.99
parietal lobe, fetal, donor1	10072-101I9	18.43	47.52	16.49
parietal lobe, newborn, donor10223	10356-105E5	16.82	30.66	6.73
parotid gland, adult	10199-103F1	6.78	1.85	0.00
penis, adult	10200-103F2	16.11	4.83	3.76
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.56	6.69	10.60
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	13.26	2.48	0.87
pineal gland - adult, donor10196	10179-103C8	46.44	49.02	16.77
pineal gland, adult, donor10252	10160-103A7	20.14	33.76	20.73
pineal gland, adult, donor10258	10377-105G8	20.69	16.30	11.29
pituitary gland - adult, donor10196	10180-103C9	33.39	33.39	11.13
pituitary gland, adult, donor10252	10162-103A9	27.10	32.31	14.59
pituitary gland, adult, donor10258	10378-105G9	24.69	15.32	11.92
placenta, adult, pool1	10021-101D3	8.06	8.71	5.05
plasma cell leukemia cell line:ARH-77	10840-111E3	6.62	2.52	5.16
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	9.18	2.33	2.49
pons, adult, pool1	10033-101E6	6.80	6.28	6.54
postcentral gyrus, adult, pool1	10032-101E5	8.19	6.45	9.94
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	5.83	3.93	4.52
prostate cancer cell line:PC-3	10439-106E7	7.62	2.18	2.18
prostate, adult, pool1	10022-101D4	17.87	6.08	4.17
putamen, adult, donor10196	10176-103C5	8.73	5.43	13.46
putamen, adult, donor10252	10152-102I8	17.65	17.65	11.76
putamen, adult, donor10258, tech_rep1	10372-105G3	5.46	6.56	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	5.80	4.11	5.56
putamen, newborn, donor10223	10365-105F5	9.00	17.24	9.00
rectal cancer cell line:TT1TKB	10469-106I1	5.24	6.40	2.33
rectum, fetal, donor1	10067-101I4	45.90	5.56	6.95
renal cell carcinoma cell line:OS-RC-2	10411-106B6	2.12	3.82	5.30
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	2.07	1.66	12.01
retina, adult, pool1	10030-101E3	12.42	12.82	15.71
retinoblastoma cell line:Y79	10475-106I7	4.16	0.52	11.17
rhabdomyosarcoma cell line:KYM-1	10787-110H4	6.27	5.66	1.60
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	2.53	4.50	3.66
sacrococcigeal teratoma cell line:HTST	10695-109G2	32.59	7.58	0.76
salivary acinar cells, donor1	11771-123I7	9.39	1.29	0.97
salivary acinar cells, donor2	11772-123I8	11.70	1.93	2.89
salivary acinar cells, donor3	11773-123I9	20.52	3.31	1.99
salivary gland, adult, pool1	10093-102C3	8.01	5.15	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	6.74	2.61	2.87
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	7.99	2.23	2.23
seminal vesicle, adult	10201-103F3	37.03	7.41	4.76
serous adenocarcinoma cell line:JHOS-2	10639-108I9	3.89	1.94	1.94
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	7.05	3.52	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	6.02	3.01	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	1.88	11.42	3.09
signet ring carcinoma cell line:Kato III	10436-106E4	11.27	1.99	2.32
signet ring carcinoma cell line:NUGC-4	10483-107A6	1.03	1.55	2.19
skeletal muscle - soleus muscle, donor1	10282-104F3	24.12	2.13	2.84
skeletal muscle, adult, pool1	10023-101D5	11.75	3.12	2.40
skeletal muscle, fetal, donor1	10066-101I3	14.07	2.01	0.00
skin, adult, donor1	10074-102A2	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	27.77	6.31	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	12.01	4.67	4.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	17.65	10.40	10.09
small cell lung carcinoma cell line:DMS 144	10841-111E4	1.54	12.91	10.41
small cell lung carcinoma cell line:LK-2	10541-107H1	2.31	2.80	5.44
small cell lung carcinoma cell line:NCI-H82	10842-111E5	1.77	6.11	28.63
small cell lung carcinoma cell line:WA-hT	10562-108A4	11.77	2.40	1.96
small intestine, adult, pool1	10024-101D6	36.91	11.47	5.49
small intestine, fetal, donor1	10064-101I1	33.41	8.35	2.46
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	23.08	11.28	3.59
smooth muscle, adult, pool1	10048-101G3	25.59	5.17	3.36
somatostatinoma cell line:QGP-1	10781-110G7	5.90	5.63	6.16
spinal cord - adult, donor10196	10181-103D1	14.68	9.64	3.44
spinal cord, adult, donor10252	10159-103A6	13.80	11.04	5.13
spinal cord, adult, donor10258	10369-105F9	6.23	12.45	4.15
spinal cord, fetal, donor1	10056-101H2	15.25	11.59	5.49
spinal cord, newborn, donor10223	10359-105E8	8.73	14.69	5.05
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	24.94	3.73	1.19
spleen, adult, pool1	10025-101D7	13.66	5.07	5.07
spleen, fetal, pool1	10044-101F8	15.65	19.39	7.87
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	6.62	3.00	4.66
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	4.94	2.09	3.04
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	5.94	6.64	6.29
squamous cell carcinoma cell line:T3M-5	10616-108G4	18.76	5.47	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	7.43	1.35	3.04
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	1.69	2.97	3.81
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	5.50	1.69	0.85
stomach, fetal, donor1	10062-101H8	26.70	7.48	5.34
submaxillary gland, adult	10202-103F4	13.10	3.42	3.99
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	17.45	17.66	4.36
substantia nigra, adult, donor10258	10371-105G2	5.17	11.38	3.10
substantia nigra, newborn, donor10223	10358-105E7	14.84	11.31	4.95
synovial sarcoma cell line:HS-SY-II	10441-106E9	5.04	6.42	2.29
temporal lobe, adult, pool1	10031-101E4	8.31	6.87	12.46
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	8.55	44.16	27.07
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	14.07	71.21	21.10
tenocyte, donor1	11763-123H8	23.39	4.89	1.75
tenocyte, donor2	11765-123I1	31.66	1.91	0.00
tenocyte, donor3	11768-123I4	18.16	2.97	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	1.02	5.78	4.76
teratocarcinoma cell line:NCR-G1	10798-110I6	4.47	4.62	4.01
teratocarcinoma cell line:PA-1	10807-111A6	2.79	5.27	4.34
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	2.92	48.49	6.60
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	0.76	14.75	11.35
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	3.49	39.37	6.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	1.63	10.10	12.70
testis, adult, pool1	10026-101D8	34.47	26.74	9.23
testis, adult, pool2	10096-102C6	64.05	56.84	13.98
thalamus - adult, donor10196	10168-103B6	14.35	8.83	5.52
thalamus, adult, donor10252	10154-103A1	14.69	14.22	7.97
thalamus, adult, donor10258, tech_rep1	10370-105G1	13.86	26.17	9.24
thalamus, adult, donor10258, tech_rep2	10370-105G1	10.05	4.61	4.45
thalamus, newborn, donor10223	10366-105F6	10.93	9.21	4.03
throat, adult	10209-103G2	17.48	5.49	6.99
throat, fetal, donor1	10061-101H7	25.29	7.62	3.66
thymic carcinoma cell line:Ty-82	10803-111A2	2.78	7.75	6.56
thymus, adult, pool1	10027-101D9	7.65	23.66	7.65
thymus, fetal, pool1	10043-101F7	25.25	50.81	20.05
thyroid carcinoma cell line:KHM-5M	10776-110G2	10.64	9.31	2.93
thyroid carcinoma cell line:TCO-1	10783-110G9	10.20	0.84	0.84
thyroid, adult, pool1	10028-101E1	10.82	7.00	3.92
thyroid, fetal, donor1	10060-101H6	26.10	7.38	3.95
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	6.16	3.08
tongue, adult	10203-103F5	10.70	1.86	3.95
tongue, fetal, donor1	10059-101H5	16.55	5.52	1.58
tonsil, adult, pool1	10047-101G2	17.13	7.41	7.91
trachea, adult, pool1	10029-101E2	7.53	4.09	3.35
trachea, fetal, donor1	10058-101H4	26.54	5.77	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	21.61	1.77	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	8.31	8.00	2.94
transitional-cell carcinoma cell line:JMSU1	10492-107B6	5.33	2.82	5.64
tridermal teratoma cell line:HGRT	10694-109G1	30.44	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	16.76	5.16	2.54
umbilical cord, fetal, donor1	10057-101H3	20.87	4.17	2.09
uterus, adult, pool1	10100-102D1	19.96	17.57	5.12
uterus, fetal, donor1	10055-101H1	17.92	5.63	4.10
vagina, adult	10204-103F6	31.02	6.46	0.65
vein, adult	10191-103E2	14.69	9.43	5.04
xeroderma pigentosum b cell line:XPL 17	10563-108A5	8.01	2.40	3.20